Results 1 to 10 of about 461,852 (357)
Blood Advances, 2023 Background Hereditary and acquired thrombophilia are risk factors for venous thromboembolism (VTE). Whether testing helps guide management decisions is controversial. Objective These evidence-based guidelines from the American Society of Hematology (ASH)
Saskia Middeldorp +2 more
exaly +2 more sources
Journal of Hematology and Oncology, 2021 Background Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients.
Livio Pagano +2 more
exaly +2 more sources
Journal of Hematology and Oncology, 2021 The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) facilitated the standardization of clinical ...
Xiao-Hui Zhang, Ming-Zhe Han, He Huang
exaly +2 more sources
How artificial intelligence might disrupt diagnostics in hematology in the near future
Oncogene, 2021 Artificial intelligence (AI) is about to make itself indispensable in the health care sector. Examples of successful applications or promising approaches range from the application of pattern recognition software to pre-process and analyze digital ...
Wencke Walter +2 more
exaly +2 more sources
Journal of Hematology and Oncology, 2018 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used to treat malignant hematological neoplasms and non-malignant hematological disorders. Approximately, 5000 allo-HSCT procedures are performed in China annually.
Ming-Zhe Han, Yong-Rong Lai, Qi-Fa Liu
exaly +2 more sources
Digital morphology analyzers in hematology: ICSH review and recommendations
International Journal of Laboratory Hematology, 2019 Morphological assessment of the blood smear has been performed by conventional manual microscopy for many decades. Recently, rapid progress in digital imaging and information technology has led to the development of automated methods of digital ...
Alexander Kratz, Szu-Hee Lee, Gina Zini
exaly +2 more sources
Blood Advances, 2021 BACKGROUND Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. OBJECTIVE These evidence-based guidelines of the American Society of
G. Lyman +15 more
semanticscholar +1 more source
Blood Advances, 2021 Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE).
A. Cuker +44 more
semanticscholar +1 more source